Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a brain tumour (such as glioma, meningioma, or brain metastases) confirmed by imaging, before receiving any chemotherapy or radiation treatment
- People between 18 and 70 years of age
- People who are able to understand the study and are willing to sign a written consent form
- People of any race or ethnicity who are able to read and speak English (the trial notes that Spanish-speaking participants will be included once the process is established)
- Women who could become pregnant must agree to use a reliable form of contraception (such as hormonal methods, barrier methods, or abstinence) from before joining the study until it ends
Who may not be able to join:
- People who are currently taking part in another clinical trial involving an experimental treatment
- People who have already had, or are currently receiving, radiation therapy or chemotherapy
- People who have other serious ongoing health conditions, including active infections, uncontrolled high blood pressure, lung, liver, or kidney disease, diabetes, heart failure, unstable chest pain, irregular heart rhythms, or mental health or personal circumstances that might make it difficult to follow the study requirements
- People with a history of alcohol abuse or illegal drug use
- People who are currently pregnant or breastfeeding, due to potential risks to the baby
- People who are medically unstable, including those with heart failure, severe heart outflow problems, or unstable chest pain
- People who have medical implants or devices that are not safe for use in an MRI scanner at 3 Tesla strength, such as pacemakers or implantable heart defibrillators (ICDs)
- People who experience severe anxiety in enclosed spaces (claustrophobia), which may make an MRI scan difficult
- People whose kidneys are not functioning well enough to safely receive the contrast dye used in the MRI scan (confirm with trial site)
- People with sickle cell disease or a condition where the body breaks down red blood cells too quickly (haemolytic anaemia)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jae Mo Park, PhD, UT Southwestern
Phone: 214-645-2726
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
13C-pyruvate Metabolic Product Ratio
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.